Cited by 2Gestational Diabetes Research and ManagementPregnancy and preeclampsia studiesMetabolomics and Mass Spectrometry Studies

Metabolic profiles in early pregnancy associated with metabolic pregnancy complications in women with obesity

Open access
Michelsen, Trond Melbye, Skytte, Hege Nyhus, Gunnes, Nina, Holven, Kirsten Bjørklund, Christensen, Jacob Juel, Roland, Marie Cecilie Paasche·2024·Journal of Reproductive Immunology

Abstract

Higher maternal body mass index (BMI) is associated with metabolic disturbances and pregnancy complications. We aimed to examine whether metabolic profiles in early pregnancy were associated with metabolic pregnancy complications in women with obesity (BMI ≥ 30 kg/m 2 ). Nested cohort study from a prospective longitudinal cohort ( n = 1031) of women who were healthy prior to pregnancy and gave birth at Oslo University Hospital from 2002–2008. The sample comprised 81 women with obesity. Metabolic pregnancy complications included gestational diabetes mellitus, gestational hypertension and preeclampsia. In plasma samples from gestational weeks 14–16, 91 metabolites were analyzed by nuclear magnetic resonance spectroscopy. We performed a principal component analysis to reduce the metabolic dimensions. Logistic regression models were fitted to estimate crude and adjusted odds ratios (ORs) of metabolic pregnancy complications. Twenty-four out of 81 women developed metabolic pregnancy complications (gestational hypertension, preeclampsia, and/or gestational diabetes). Two of five principal components (80 % explained variance) were significantly associated with metabolic pregnancy complications. The ratio of monounsaturated to total fatty acids increased the risk of metabolic pregnancy complications (OR 2.09, 95 % confidence interval [CI] 1.25–3.75), while the ratio of polyunsaturated to monounsaturated fatty acids decreased the risk (OR 0.54, 95 % CI 0.30–0.89). The ratio of omega-3 to total fatty acids (OR 0.59, 95 % CI 0.34–0.98) and the ratio of docosahexaenoic acid to total fatty acids (OR 0.57, 95 % CI 0.31–0.97) also decreased the risk of metabolic pregnancy complications. Metabolic profile in early pregnancy was associated with risk of metabolic pregnancy complications in women with obesity. We observed the strongest associations between fatty acid composition and metabolic pregnancy complications. Graphcal abstract created with BioRender.com. The map of Norway is generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license. • Maternal obesity was associated with metabolic disturbances and pregnancy complications. • Maternal early pregnancy metabolites were associated with metabolic pregnancy complications. • Higher monounsaturated fatty acids increased the risk of metabolic pregnancy complications. • Higher polyunsaturated fatty acids, omega-3, and DHA decreased the risk of metabolic pregnancy complications. • Future studies should investigate whether interventions aimed to improve fatty acid composition could prevent pregnancy complications.

Integrity signals

Registry

Crossref · 10.1016/j.jri.2024.104397

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Michelsen, T. M., Skytte, H. N., Gunnes, N., Holven, K. B., Christensen, J. J., & Roland, M. C. P.
Affiliations
  • Oslo University Hospital (NO)
  • University of Oslo (NO)
Corresponding author
Michelsen, Trond Melbye
Venue
Journal of Reproductive Immunology
Publisher
Elsevier BV
Published
2024-12
Volume
166
Pages
104397
ISSN
0165-0378 (ISSN-L)
OpenAlex
W4404504349
Cited by
2
References
52
Citations by year
2026: 2
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • Journal of Reproductive Immunology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
maternal obesity, early pregnancy, plasma metabolites, fatty acid composition, monounsaturated fatty acids, polyunsaturated fatty acids, omega-3 fatty acids, docosahexaenoic acid, gestational diabetes mellitus, gestational hypertension, preeclampsia, body mass index, metabolomic biomarkers, risk prediction
MeSH terms
Adult, Female, Humans, Longitudinal Studies, Obesity, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Prospective Studies, Cohort Studies, Body Mass Index, Diabetes, Gestational, Hypertension, Pregnancy-Induced, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review